Instytut Biotechnologii i Medycyny Molekularnej
Independent research and implementation institute conducting interdisciplinary biomedical R&D in diagnostics, molecular biology, biomaterials, sensor technologies and environmental remediation. Provides laboratory infrastructure and collaborative services, develops point-of-care diagnostics, electrochemical and optical sensors, wearable biochemical monitors and reactive materials, and participates in nationally and EU-funded research programs (e.g., TECHMATSTRATEG, POIR, TEAM-NET).
Industries
Nr. of Employees
small (1-50)
Instytut Biotechnologii i Medycyny Molekularnej
Patents
Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer
US-10556925-B2
View Details
Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer
US-10556925-B2
View DetailsProducts
Bioinformatics AI platform for peptide–protein interaction screening
Software platform using machine learning to generate virtual peptide libraries and predict peptide–protein binding to support ligand selection for diagnostic assays.
Machine-learning posture analysis system
Non-invasive ML-based system for automated screening and interpretation of postural defects in children and adolescents to support early detection and rehabilitation planning.
Electrochemical water remediation reactor with AI control
Laboratory-validated electrochemical reactor prototype combining modified reticulated carbon foams and AI-based parameter optimization for removal of pharmaceuticals and emerging contaminants from water.
Rapid SNP genotyping system for forensic use
Development of a rapid, mobile genotyping test intended to generate forensic genetic profiles with electronic result recording.
Point-of-care panels for vaginal and streptococcal infections
Rapid PoC assays for species-level identification of vaginal pathogens and Streptococcus spp., with concurrent antibiotic-resistance marker detection to inform treatment.
Veterinary and aquaculture pathogen PoC tests
Rapid diagnostics for on-site detection of pathogens in horses and farmed shrimp to support outbreak management and monitoring.
Bioinformatics AI platform for peptide–protein interaction screening
Software platform using machine learning to generate virtual peptide libraries and predict peptide–protein binding to support ligand selection for diagnostic assays.
Machine-learning posture analysis system
Non-invasive ML-based system for automated screening and interpretation of postural defects in children and adolescents to support early detection and rehabilitation planning.
Electrochemical water remediation reactor with AI control
Laboratory-validated electrochemical reactor prototype combining modified reticulated carbon foams and AI-based parameter optimization for removal of pharmaceuticals and emerging contaminants from water.
Rapid SNP genotyping system for forensic use
Development of a rapid, mobile genotyping test intended to generate forensic genetic profiles with electronic result recording.
Point-of-care panels for vaginal and streptococcal infections
Rapid PoC assays for species-level identification of vaginal pathogens and Streptococcus spp., with concurrent antibiotic-resistance marker detection to inform treatment.
Veterinary and aquaculture pathogen PoC tests
Rapid diagnostics for on-site detection of pathogens in horses and farmed shrimp to support outbreak management and monitoring.
Services
Provision of laboratory space, administrative and logistical support, and flexible collaboration models for external teams and R&D projects.
Standardized in vitro cytotoxicity assays for solid biomaterials and biomaterial components to support safety assessment and preclinical development.
Provision of laboratory space, administrative and logistical support, and flexible collaboration models for external teams and R&D projects.
Standardized in vitro cytotoxicity assays for solid biomaterials and biomaterial components to support safety assessment and preclinical development.
Expertise Areas
- Point-of-care diagnostics
- Electrochemical biosensing and electroanalytical methods
- Bioinformatics and AI for peptide–protein interaction screening
- Nanomaterials and antimicrobial surface coatings
Key Technologies
- Electrochemical impedance spectroscopy
- Reticulated vitreous carbon / reticulated carbon foam electrodes
- Boron-doped diamond and nanocrystalline carbon electrode materials
- Antibody/peptide-modified electrode interfaces
News & Updates
Press events announcing progress on an AI-integrated electrochemical reactor project for removal of water contaminants; meetings held 14 March 2024 and 18 April 2024 in Gdańsk.
Inauguration of a private R&D center in Gdańsk hosting IBMM operations to support biomedical projects and a regional diagnostic cluster.
Multiple publications in journals describing electrochemical biosensors, boron-doped diamond electrodes, anodic oxide coatings, biomaterials and related methods.
Leadership and participation in multiple nationally and EU-funded consortia across diagnostics, materials and environmental technologies (examples include TECHMATSTRATEG, POIR, TEAM‑NET and Norweskie Mechanizmy projects).
Project on biopolymer materials with chemically/genetically programmed selectivity for ultrahigh-sensitivity heavy-metal biosensors. Total project value: 18,458,913.97 PLN; funding: 18,362,616.32 PLN. Period: 2021-01-01 to 2023-12-31.
Development of an electrochemical reactor using modified reticulated carbon foams and AI for contaminant removal. Total project value: 6,930,210.68 PLN; funding: 6,850,085.68 PLN. Period: 2020-10-01 to 2024-04-30. IBMM is project leader for the consortium.
Press events announcing progress on an AI-integrated electrochemical reactor project for removal of water contaminants; meetings held 14 March 2024 and 18 April 2024 in Gdańsk.
Inauguration of a private R&D center in Gdańsk hosting IBMM operations to support biomedical projects and a regional diagnostic cluster.
Multiple publications in journals describing electrochemical biosensors, boron-doped diamond electrodes, anodic oxide coatings, biomaterials and related methods.
Leadership and participation in multiple nationally and EU-funded consortia across diagnostics, materials and environmental technologies (examples include TECHMATSTRATEG, POIR, TEAM‑NET and Norweskie Mechanizmy projects).
Project on biopolymer materials with chemically/genetically programmed selectivity for ultrahigh-sensitivity heavy-metal biosensors. Total project value: 18,458,913.97 PLN; funding: 18,362,616.32 PLN. Period: 2021-01-01 to 2023-12-31.
Development of an electrochemical reactor using modified reticulated carbon foams and AI for contaminant removal. Total project value: 6,930,210.68 PLN; funding: 6,850,085.68 PLN. Period: 2020-10-01 to 2024-04-30. IBMM is project leader for the consortium.